MedPath

Theophylline

Theophylline Extended-Release Tablets Rx only

Approved
Approval ID

6bc8923e-b7db-40a5-b22a-a975ca2bf1fd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2017

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Theophylline

PRODUCT DETAILS

NDC Product Code68151-1393
Application NumberANDA090430
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 5, 2016
Generic NameTheophylline

INGREDIENTS (5)

THEOPHYLLINE ANHYDROUSActive
Quantity: 300 mg in 1 1
Code: 0I55128JYK
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Theophylline - FDA Drug Approval Details